November 21, 2012 16:01 ET
BROSSARD, QUEBEC, CANADA--(Marketwire - Nov. 21, 2012) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces today an extension of 15 months to the term for exercise of the eligible warrants issued as part of the most recent private placement.
The original term was November 26, 2012. With the extension of 15 months, the eligible outstanding warrants are now exercisable up to February 26, 2014 (the "Expiry date"). Each warrant entitles its holder to acquire one common share at an unchanged price of $0.40 up to the Expiry date. As initially stated, each warrant carries a forced conversion feature as such that should the common shares of the Corporation trade at or above $0.60 for twenty consecutive trading days at any time up to the Expiry date, then all of the warrants shall be exercised within 30 days or they will automatically expire.
The amendment to warrant term is subject to TSX Venture acceptance.
All monies quoted in this press release shall be stated in lawful money of Canada.
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.
For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Andre Larente, PresidentDIAGNOS firstname.lastname@example.orgLouis MorinBid Capital Markets514email@example.com
See all RSS Newsfeeds